Pfizer to Acquire Obesity-Drug Maker Metsera for $4.9 Bn

This is Beirut, 15:30 - Reading : 1 minute(s)

USA Pharmaceutical Obesity Pfizer Metsera

US pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday. With the purchase Pfizer aims to expand its portfolio by entering the huge and growing market for medicines to treat obesity. "Obesity is a large and growing space with over 200 health conditions ...